Home › Lung Diseases › California › Newport Beach
Lung Diseases clinical trials in Newport Beach, CA
4 studies for Lung Diseases are looking for participants at sites in and around Newport Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
RecruitingPhase 2
- NewportNativeMD, Inc., Newport Beach
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Newport Beach
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RecruitingPhase 3
- Hoag Hospital Newport Beach, Newport Beach
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RecruitingPhase 2
- NewportNativeMD, Inc., Newport Beach
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Miami, FL10 studies
- Dallas, TX10 studies
- Columbus, OH10 studies
- Nashville, TN10 studies
- Los Angeles, CA10 studies
- Washington, DC10 studies
- Ann Arbor, MI10 studies
Other studies in Newport Beach
- Breast Cancer16 studies
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer10 studies
- COPD9 studies
- Ovarian Cancer9 studies
- Endometrial Cancer7 studies
- Lung Cancer7 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Triple-Negative Breast Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.